Flagship Pioneering to establish first major UK biotech hub with £600 million investment plan
Flagship Pioneering founder Noubar Afeyan said the firm aims to raise as much as £600 million for its new UK investment, creating a full‑scale biotech company‑creation platform that will use AI to accelerate drug discovery. The move marks Flagship’s first major operation outside the US and highlights the need for regulatory safeguards around autonomous AI in biotech.